UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME
Sales, net (notes 1, 3, 9 and 11)	$ 40,903	$ 50,224	$ 52,281
Cost of goods sold	16,760	20,186	20,085
Gross profit	24,143	30,038	32,196
Operating expense
Sales and marketing	1,901	1,685	1,507
Research and development	813	560	493
General and administrative	7,835	11,016	10,406
Operating income	13,594	16,777	19,790
Other income (expense)
Dividend and interest income	3,367	3,036	661
Royalty income (note 12)	15	20	20
Other, net	(174)	256	188
Income before provision for income taxes	16,802	20,089	20,659
Provision for income taxes (note 7)	2,928	3,454	4,186
Net income	$ 13,874	$ 16,635	$ 16,473
Earnings per common share (basic) (note 1)	$ 3.96	$ 4.58	$ 4.53
Earnings per common share (diluted)	$ 3.96	$ 4.57	$ 4.52
Foreign currency translation net of taxes of $0 in all periods	$ (1,249)	$ 1,381	$ (2,986)
Total comprehensive income	$ 12,625	$ 18,016	$ 13,487